Abstract
Personalized medicine aims to tailor drug therapy based on individual genetic profiles to improve efficacy and minimize adverse effects. A key component of personalized medicine is the understanding of drug metabolism and pharmacogenetics, which involve genetic variations that affect drug absorption, distribution, metabolism, and excretion. This article explores the role of pharmacogenetics in drug metabolism and its application in personalized medicine. We discuss how genetic polymorphisms in drug-metabolizing enzymes, transporters, and receptors influence drug responses and the potential for optimizing drug therapy based on genetic testing .
All articles published in the American Journal of Pharmacy and Pharmacology are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given to the original author(s) and source, a link to the license must be provided, and any changes made must be indicated.
By submitting their work, authors agree to these licensing terms and retain copyright of their articles.